GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (MEX:GEHC) » Definitions » Book Value per Share

GE HealthCare Technologies (MEX:GEHC) Book Value per Share : MXN410.51 (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is GE HealthCare Technologies Book Value per Share?

GE HealthCare Technologies's book value per share for the quarter that ended in Mar. 2025 was MXN410.51.

During the past 12 months, GE HealthCare Technologies's average Book Value Per Share Growth Rate was 23.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -20.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of GE HealthCare Technologies was -20.40% per year. The lowest was -21.50% per year. And the median was -20.95% per year.

GE HealthCare Technologies's current price is MXN1394.00. Its book value per share for the quarter that ended in Mar. 2025 was MXN410.51. Hence, today's PB Ratio of GE HealthCare Technologies is 3.40.

During the past 6 years, the highest P/B Ratio of GE HealthCare Technologies was 5.99. The lowest was 1.53. And the median was 4.73.


GE HealthCare Technologies Book Value per Share Historical Data

The historical data trend for GE HealthCare Technologies's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies Book Value per Share Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Book Value per Share
Get a 7-Day Free Trial 644.26 751.38 401.82 265.90 385.48

GE HealthCare Technologies Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 269.42 312.96 358.46 385.48 410.51

Competitive Comparison of GE HealthCare Technologies's Book Value per Share

For the Health Information Services subindustry, GE HealthCare Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GE HealthCare Technologies's PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's PB Ratio falls into.


;
;

GE HealthCare Technologies Book Value per Share Calculation

GE HealthCare Technologies's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(176,147-0)/457
=385.48

GE HealthCare Technologies's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(187,949-0)/458
=410.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


GE HealthCare Technologies  (MEX:GEHC) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


GE HealthCare Technologies Book Value per Share Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


GE HealthCare Technologies Business Description

Traded in Other Exchanges
Address
500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).